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abstract
 
The ﬁve KCNE genes encode a family of type I transmembrane peptides that assemble with KCNQ1
and other voltage-gated K
 
 
 
 channels, resulting in potassium conducting complexes with varied channel-gating
properties. It has been recently proposed that a triplet of amino acids within the transmembrane domain of
KCNE1 and KCNE3 confers modulation speciﬁcity to the peptide, since swapping of these three residues essentially
converts the recipient KCNE into the donor (Melman, Y.F., A. Domenech, S. de la Luna, and T.V. McDonald.
2001. 
 
J. Biol. Chem.
 
 276:6439–6444). However, these results are in stark contrast with earlier KCNE1 deletion studies,
which demonstrated that a COOH-terminal region, highly conserved between KCNE1 and KCNE3, was responsible
for KCNE1 modulation of KCNQ1 (Tapper, A.R., and A.L. George. 2000 
 
J. Gen. Physiol.
 
 116:379–389.). To ascertain
whether KCNE3 peptides behave similarly to KCNE1, we examined a panel of NH
 
2
 
- and COOH-terminal KCNE3
truncation mutants to directly determine the regions required for assembly with and modulation of KCNQ1
channels. Truncations lacking the majority of their NH
 
2
 
 terminus, COOH terminus, or mutants harboring both
truncations gave rise to KCNQ1 channel complexes with basal activation, a hallmark of KCNE3 modulation. These
results demonstrate that the KCNE3 transmembrane domain is sufﬁcient for assembly with and modulation of
KCNQ1 channels and suggests a bipartite model for KCNQ1 modulation by KCNE1 and KCNE3 subunits. In this
model, the KCNE3 transmembrane domain is active in modulation and overrides the COOH terminus’ contribution,
whereas the KCNE1 transmembrane domain is passive and reveals COOH-terminal modulation of KCNQ1
channels. We furthermore test the validity of this model by using the active KCNE3 transmembrane domain to
functionally rescue a nonconducting, yet assembly and trafﬁcking competent, long QT mutation located in the
conserved COOH-terminal region of KCNE1.
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INTRODUCTION
 
The KCNE type I transmembrane peptides (
 
 
 
125
residues) are a family of tissue-speciﬁc 
 
 
 
-subunits that
associate with and ﬁne tune the electrical properties of
several voltage-gated K
 
 
 
 channels (Abbott et al., 1999,
2001; Yu et al., 2001; Zhang et al., 2001; Grunnet et al.,
2003; McCrossan et al., 2003; Lewis et al., 2004). In
expression systems, KCNQ1 (Q1) K
 
 
 
 channels have
afﬁnity for all ﬁve KCNE peptides forming K
 
 
 
 conducting
complexes with different voltage activation, gating ki-
netics, unitary conductance, and pharmacology (Bar-
hanin et al., 1996; Sanguinetti et al., 1996; Sesti and
Goldstein, 1998; Schroeder et al., 2000; Tinel et al.,
2000; Angelo et al., 2002; Grunnet et al., 2002). Of these
complexes, the physiological roles of the Q1-KCNE1
(E1) and Q1-KCNE3 (E3) complexes have been well
established. In the heart, Q1–E1 complexes constitute
the slowly activating and deactivating cardiac I
 
Ks
 
 current
(Barhanin et al., 1996; Sanguinetti et al., 1996). Mutations
in either Q1 or E1 that disrupt channel function and
prolong the cardiac action potential have been impli-
cated in several inherited forms of long QT syndrome
(Splawski et al., 2000). Q1–E3 complexes have been
detected in the basolateral membranes of several epi-
thelial tissues where these apparently constitutively open
channels are critical for cAMP-stimulated chloride secre-
tion in colon and lung (Schroeder et al., 2000; Graham-
mer et al., 2001). Given their connectivity to chloride
secretion, Q1–E3 complexes may be potential targets
for cystic ﬁbrosis therapies (Cowley and Linsdell, 2002;
Cuthbert and MacVinish, 2003).
Numerous studies have examined the molecular
interactions between E1 and Q1. Two independent
cysteine mutagenesis studies have demonstrated that
the E1 peptides are intimate with the ion conducting
pore unit, yet these studies disagree on the peptides’
exact location (Wang et al., 1996; Tai and Goldstein,
1998; Tapper and George, 2001). Deletion studies of
E1 have shown that the transmembrane segment is suf-
ﬁcient for assembly with Q1, whereas a COOH-terminal
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region of 
 
 
 
25 amino acids proximal to the cytoplasmic
membrane is necessary for Q1 modulation (Takumi et
al., 1991; Tapper and George, 2000). These results are
in sync with the long QT mutations found in E1 that re-
side within this same region (Splawski et al., 1997; Bian-
chi et al., 1999). However, recent studies with KCNE1/
3 chimeras suggest that a triplet of amino acids within
the transmembrane segment of either KCNE is sufﬁ-
cient for modulation of Q1, and it was proposed that
the COOH terminus, which is so well conserved be-
tween E1 and E3, is merely required for proper anchor-
ing or positioning of the transmembrane domain (Mel-
man et al., 2001). In a subsequent report, this modula-
tion speciﬁcity was further rendered down to a single
amino acid within the triplet: T58/V72 in E1/E3 (Mel-
man et al., 2002a). To date, however, the interaction be-
tween E3 and Q1 has not been directly examined.
We sought to determine the regions of E3 responsi-
ble for assembly with and modulation of Q1 channels
by constructing a panel of E3 truncation mutants and
coexpressing them with Q1 channels. We ﬁnd a double
truncation mutant composed essentially of the E3
transmembrane domain assembles with Q1 channels,
producing K
 
 
 
 channel complexes that are open at hy-
perpolarizing potentials. This mutant directly demon-
strates that the E3 transmembrane domain is sufﬁcient
for assembly with Q1; by analogy, we predict this will be
the case for all KCNE peptides. These results suggest a
bipartite model for modulation of Q1 channels by E3
and E1 where the transmembrane domain is either ac-
tive in modulation (E3) and masks the contribution of
the COOH terminus, or is passive (E1) and reveals
COOH-terminal modulation of Q1. We further corrob-
orate the bipartite model by using an “active” E3 trans-
membrane domain to override a nonfunctional long
QT mutation located in the COOH terminus of E1.
 
MATERIALS AND METHODS
 
Mutagenesis and cRNA Preparation
 
KCNQ1 and KCNE3 were subcloned into vectors containing the
5
 
 
 
 and 3
 
 
 
 UTRs from the 
 
Xenopus
 
 
 
 
 
-globin gene for optimal
protein expression. KCNE3 mutations were introduced using
Quikchange (Stratagene) and conﬁrmed by DNA sequencing.
The HA tag, PYDVPDYA, was incorporated into the NH
 
2
 
 termi-
nus of E3 between residues 11 and 12 (Abbott et al., 2001). Plas-
mids were linearized with MluI, and RNA synthesized by run-off
transcription using SP6 (Promega).
 
Oocyte Preparation and cRNA Injection
 
Mature oocytes were surgically extracted from anesthetized 
 
Xe-
nopus laevis
 
. Isolated oocytes were mechanically separated and
bathed in OR2 (in mM): 82.5 NaCl, 2.5 KCl, 1 MgCl
 
2
 
, 5 HEPES,
pH 7.4 
 
 
 
 2 mg/ml collagenase (Worthington Biochemical Corp.)
for 85–95 min to remove ovarian material and follicles. After rins-
ing, oocytes were incubated overnight at 18
 
 
 
C in ND96-bathing
(ND96B) solution 
 
 
 
 gentamicin (in mM): 96 NaCl, 2 KCl, 1.8
CaCl
 
2
 
, 1 MgCl
 
2
 
, 5 HEPES, 50 
 
 
 
g/ml gentamicin (Sigma-Aldrich),
pH 7.4. Oocytes were microinjected with RNA 12–50 h after ex-
traction with 27.6 nl total volume of cRNA solution. Oocytes were
injected with (ng/oocyte) Q1, 15; Q1/E3, 7.5/3.5; Q1/E3 trunca-
tion, 5/3.5; Q1/KCNE D
 
→
 
N mutant, 7.5/18.5. For experiments
in which E3 cRNA injection ratios were compared, Q1 was kept
constant at 7.5 ng/oocyte, while the quantity of E3 was varied,
18.5, 3.0, 0.7, and 0.4 ng/oocyte. Likewise, in experiments using
HA-tagged E3 constructs, Q1 was kept constant at 7.5 ng/oocyte,
and was coinjected with E3 (3.0 or 0.4 ng/oocyte). In controls
where only Q1 or E3 was injected, an equivalent volume of DEPC
water was also injected. Injected oocytes were incubated at 18
 
 
 
C in
ND96B 
 
 
 
 gentamicin for 2–7 d before conducting experiments.
 
Electrophysiology
 
Currents were measured using two-electrode voltage clamp (OC-
725-C; Warner Instrument Corp.) and data acquired with Digidata
1322A (Axon Instruments) running Clampex 8.2 (Axon Instru-
ments) at RT. Electrodes were ﬁlled with 3 M KCl, 5 mM EGTA, 10
mM HEPES, pH 7.6, and had resistance between 0.2 and 1.5 M
 
 
 
.
A home-made gravity-fed perfusion chamber was used, in which
complete solution exchange occurred within 
 
 
 
10 s.
Q1–E3 channels are open at negative membrane potentials,
and thus several steps were taken to ensure that the currents
measured are from K
 
 
 
 selective currents and not from nonspe-
ciﬁc leak. Oocytes injected with wild-type (WT) and mutant E3
cRNA were only recorded from if the resting membrane poten-
tial was more negative than 
 
 
 
75 mV in ND96, since oocytes with
more positive resting potentials routinely had nonspeciﬁc leak
and/or were dead. ND96 (in mM): 96 NaCl, 2 KCl, 0.3 CaCl
 
2
 
, 1
MgCl
 
2
 
, 5 HEPES, pH 7.0. For experiments using solutions with
K
 
 
 
 concentrations greater than ND96, the current at 
 
 
 
80 mV
was measured in ND96 before and after each experiment. Data
was only included if current at 
 
 
 
80 mV returned to the original
level in ND96 after treatment with high K
 
 
 
 solution. The major-
ity of the E3 mutants had positive current at 
 
 
 
80 mV due to out-
ward “leak” of potassium, presumably through the Q1–E3 chan-
nels. For Q1, the leak current at 
 
 
 
80 mV was between 
 
 
 
0.01 and
 
 
 
0.04 
 
 
 
A in ND96. All traces shown were not leak subtracted.
Tail currents for activation curves were measured in KD98 (in
mM): 98 KCl, 0.3 CaCl
 
2
 
, 1 MgCl
 
2
 
, 5 HEPES, pH 7.0. Upon switch-
ing the external solution to KD98, oocytes were held at 
 
 
 
80 mV
until the inward current plateaued. The tail current protocol was
a series of command pulses to potentials between 
 
 
 
100 and 
 
 
 
60
mV in 10-mV increments for 2 s, after which oocytes were re-
turned to 
 
 
 
80 mV. The interpulse interval was 13 s.
Reversal potentials were measured at several external potas-
sium concentrations, each isotonically balanced with sodium.
The reversal potential protocol was a holding potential of 
 
 
 
80
mV, depolarizing to 
 
 
 
40 mV for 2 s, followed by repolarization to
potentials around the Nernst-predicted value of E
 
K
 
 in 2-mV steps
to determine the reversal potential.
Chromanol 293B inhibition was measured in ND96C (in mM):
96 NaCl, 2 KCl, 1.8 CaCl
 
2
 
, 1 MgCl
 
2
 
, 5 HEPES, pH 7.4. Chromanol
293B (Tocris) was added to ND96C from a 10 mM stock in
DMSO. The ﬁnal concentration of DMSO in ND96C was 0.1%.
Oocytes were held at 
 
 
 
80 mV and subjected to 
 
 
 
40 mV depolar-
izations for 2 s every 30 s until the current level stabilized (
 
 
 
5
min). After the current stabilized, 10 
 
 
 
M chromanol 293B was
perfused until inhibition was complete (
 
 
 
5 min), and the re-
maining current was measured.
Oocytes expressing complexes with HA-tagged E3 proteins be-
came appreciably inactivated during incubation at 18
 
 
 
C in ND96B.
Cumulative inactivation was removed by holding at 
 
 
 
80 mV in
ND96 with periodic test depolarization to 
 
 
 
40 mV to monitor re-
lief of inactivation. After relieving inactivation, oocytes were sub-
jected to a family of depolarizations from 
 
 
 
100 to 
 
 
 
40 mV in 20- 
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mV steps with a 13-s interpulse interval. Cumulative inactivation
was monitored using a 2-s test depolarization from 
 
 
 
80 to 
 
 
 
40 mV
at 30-s intervals. At ﬁrst, isochronal current measurements were
taken 100 ms before the respective capacitive transients at 
 
 
 
80 and
 
 
 
40 mV in ND96 solution. Then, the bath solution was changed to
KD98, and the current was then measured until there was no
change in current between test depolarizations. A family of cur-
rents was then measured in KD98 using the same depolarization
protocol used with ND96. Recovery from cumulative inactivation
was monitored by returning the bath solution to ND96 and mea-
suring the current at 
 
 
 
80 mV and 
 
 
 
40 mV as described above.
To detect the voltage-dependent inactivation of homotet-
rameric Q1 channels with the HA-tagged E3 constructs, the oo-
cytes were held at 
 
 
 
40 mV and bathed in RD10 solution, which
minimized cumulative inactivation, yet enabled the visualization
of inward currents (in mM): 88 NaCl, 10 RbCl, 0.3 CaCl
 
2
 
, 1
MgCl
 
2
 
, 5 HEPES, pH 7.4. The pulse protocol used a holding po-
tential of 
 
 
 
40 mV, a 2-s test pulse between 
 
 
 
100 and 
 
 
 
60 in 20-
mV increments, followed by a tail pulse to 
 
 
 
80 mV for 1.5 s. The
interpulse interval was 11.5 s.
 
Data Analysis
 
The amplitude of the tail currents were measured 3 ms after re-
turn to 
 
 
 
80 mV and plotted versus the depolarized potential.
The resultant activation curves were initially ﬁt to a Boltzmann
function,  , where V
 
1/2
 
 is
the midpoint of activation and z is the maximum slope. The up-
per and lower asymptotes, A1 and A2, respectively, were left to
vary, allowing data to be ﬁt in cases where channels did not fully
close or were not fully activated in the voltage ranges that can be
used with oocytes (
 
 
 
100 to 
 
 
 
60 mV). After the initial ﬁt, the tail
current amplitudes were normalized such that the upper asymp-
tote (A1) was equal to 1. These data were reﬁt to the Boltzmann
function, and the lower asymptote (A2) of the second ﬁt was
used to compare basal activation of the wild type and mutant
Q1–E3 complexes. Deactivation time constants were measured
by ﬁtting the current at 
 
 
 
80 mV following a (40–60 mV) depolar-
ization to a single or double exponential. Time constants of deac-
tivation were not determined in samples where recovery from in-
activation obscured the fast component of deactivation.
 
Oocyte Membrane Preparation
 
3–5 d after injection with 7.5 ng Q1 and E3 (3.0 or 0.4 ng cRNA/
oocyte), several oocytes were checked for functional K
 
 
 
 conduct-
ing complexes, and each batch of oocytes was homogenized at
4
 
 
 
C in 0.9 ml homogenization buffer, 100 mM HEPES, pH 7.6, 1
mM EDTA, 50 mM DTT, and 100 
 
 
 
g/ml PMSF. Subsequent steps
were performed at 4
 
 
 
C. The cell debris from the homogenate
was pelleted (3,000 
 
g
 
, 10 min), and the supernatant was col-
lected. The pellet was vigorously resuspended in homogenization
buffer (0.9 ml) and cell debris was pelleted again (3,000 
 
g
 
, 10
min). The supernatants were combined and overlaid on a 15%
sucrose cushion, prepared with 100 mM HEPES, pH 7.6, and 10
mM 
 
N
 
-ethyl maleimide. Samples were subjected to ultracentrifu-
gation (175,000 
 
g
 
, 75 min), and pelleted membranes were deter-
gent solubilized at RT in 1% SDS, 150 mM NaCl, 100 mM DTT,
10 mM TRIS-HCl, pH 7.5. Since a proportionally smaller volume
of solubilization buffer per oocyte was used for oocytes injected
with 0.4 ng of mutant E3 cRNA, these membranes were solubi-
lized with 5% SDS to aid in solubilization.
 
SDS-PAGE and Western Blot
 
SDS-solubilized membranes were diluted with 1/5 volume of 6
 
 
 
SDS-PAGE loading buffer, and the proteins were separated on ei-
yA 2A 1 A 2 – () 1e
VV 1/2 – () *  zF/RT () + () ⁄ + =
 
ther a 15% SDS-PAGE (TRIS/glycine) or 16.5% (TRIS/tricine)
(Schagger and von Jagow, 1987). Proteins were transferred to ni-
trocellulose (0.2 
 
 
 
m pore size) at constant amperage (0.2–0.3 A)
for 1 h. Blots were blocked for 45 min at RT in blocking buffer
(5% nonfat milk in Western wash: 150 mM NaCl, 10 mM TRIS-
HCl, pH 7.4, and 0.2% Tween-20). The blots were incubated
overnight at 4
 
 
 
C with 100 ng/ml rat monoclonal 
 
 
 
-HA (Roche)
in blocking buffer. Blots were washed in Western wash (3 
 
 
 
 5
min) and incubated for 45 min at RT with 200 ng/ml goat 
 
 
 
-rat
HRP (Santa Cruz Biotechnology, Inc.) in blocking buffer. After
washing (3 
 
 
 
 5 min) in Western wash, the blot was developed in
SuperSignal West Dura Extended Duration Substrate (Pierce)
for 5 min, and the immunoreactive bands were captured using a
Fujiﬁlm LAS-3000 CCD Camera.
 
PNGase F and Endo H Analysis
 
SDS-solubilized membranes as described above were diluted to
0.5% SDS with an equal volume of water and then raised to 1%
NP-40 and 50 mM sodium citrate, pH 5.5, or 50 mM sodium
phosphate, pH 7.5, and digested with Endo H
 
f
 
 or PNGase F (New
England Biolabs), respectively, at 37
 
 
 
C for 1 h. After digestion,
samples were raised to a total of 75 mM DTT and 3.5% SDS and
then mixed with 6
 
 
 
 gel loading buffer, and the proteins were re-
solved on SDS-PAGE and analyzed by Western blot as described
above.
 
Cell Surface Labeling and Luminometry
 
The level of cell surface HA-tagged E3 proteins was measured by
luminometry as previously reported (Zerangue et al., 1999). Oo-
cytes were injected with 7.5 ng Q1 and WT or mutant E3–HA (3.0
or 0.4 ng). Control oocytes were injected with only 7.5 ng Q1
cRNA. On day 5 post-injection, a few oocytes were checked
for functioning channel complexes, and then the oocytes were
cooled to 4
 
 
 
C in ND96B to prevent further trafﬁcking. Oocytes
were blocked for 30 min with 1% BSA in ND96B. Oocytes were
then incubated for 1 h with 1 
 
 
 
g/ml rat monoclonal 
 
 
 
-HA
(Roche) in 1% BSA in ND96B. Oocytes were washed (8 
 
 
 
 5 min)
with 1% BSA in ND96B and incubated for 40 min with secondary
 
 
 
-rat F(ab)
 
2
 
 antibody (Jackson ImmunoResearch Laboratories)
added at 2  g/ml in 1% BSA in ND96B. Secondary antibody was
removed and washed once with 1% BSA ND96B for 1 h followed
by a second wash in ND96B for 1 h. Oocytes were individually
placed in wells with 50  l of ND96B solution, mixed with 50  l of
SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce
Chemical Co.), and the signal at 405 nm was integrated for 15 s
using a Mediators PhL Luminometer (Aureon Biosystems). Data
is given in relative light units, RLU, and comes from the same
batch of oocytes.
RESULTS
Expression of homomeric Q1 channels (Fig. 1 A, left)
gives rise to outwardly rectifying K  currents that un-
dergo inactivation, which can be readily detected upon
repolarization as a hook in the tail currents since the
rate of recovery from inactivation is faster than deacti-
vation (Pusch et al., 1998). In contrast, coexpression of
Q1 with E3 produces a K  conducting complex that
displays no inactivation and has large standing currents
at hyperpolarizing potentials (Fig. 1 A, right). The
standing currents are caused by the large basal activa-
tion of the complex, which is compared with homo-
meric Q1 channels using the voltage–activation rela-762 KCNE3 Truncation Mutants
tionship in Fig. 1 B. Using this comparative analysis,
the basal activation of the Q1–E3 complex is  30%,
whereas Q1 channels are relatively closed (3%). To
directly determine the regions of E3 required for as-
sembly with and modulation of Q1 channels, we con-
structed a panel of E3 truncation mutants (Fig. 2), co-
expressed them with Q1 channels in Xenopus oocytes,
and analyzed them using two-electrode voltage clamp
(TEVC).
We ﬁrst examined whether removal of the NH2 termi-
nus altered E3 s ability to assemble with and modulate
Q1 channels. A series of overlapping NH2-terminal par-
tial truncation mutants were constructed such that ev-
ery NH2-terminal amino acid, except for the ﬁrst four
residues, was absent in at least one construct. All NH2-
terminal mutants shown in Fig. 3 A rapidly activate and
deactivate, lack inactivation, and have large standing
currents at negative potentials in response to families
of command voltages. Glycosylation of E3 appears to be
required for complex assembly and/or function since
severe NH2-terminal mutants that removed every puta-
tive N-linked glycosylation site did not express current
when coinjected with Q1 (unpublished data). Like WT
E3, expression of NH2-terminal truncation mutants
alone did not yield any appreciable current over unin-
jected controls (unpublished data). In fact, all E3 mu-
tants studied did not afford currents above background
when injected without Q1 RNA. Functional Q1–E3
NH2-terminal truncation complexes were compared us-
ing voltage activation curves (Fig. 3 B). This compari-
son is valid, provided that the conducting complexes
can be nearly maximally activated to accurately ﬁt the
upper asymptote of the Boltzmann equation, as is the
case for  5-40 and  10-51. In the case of the  41-55
mutant, the curve is markedly right shifted and not
amenable to this comparative analysis. Nonetheless, it
is clear from the families of current traces that the NH2-
terminal sequence (barring glycosylation) is not re-
quired for Q1–E3 complex assembly and function.
Given the high degree of sequence homology be-
tween the COOH termini of E1 and E3, we next deter-
mined whether the COOH terminus of E3 is active in
modulation of and assembly with Q1 channels. Fig. 4
shows representative data from a COOH-terminal trun-
cation mutant ( 84) and a double truncation ( 10-51/
 84) mutant coexpressed with Q1. From these data, it
is clear that E3 peptides lacking their COOH termini
can assemble with Q1 channels and form conducting
complexes that have standing currents at hyperpolariz-
ing potentials with unaltered K  selectivity (Fig. 4 C).
However, removal of the COOH terminus does come
with a cost; these mutants display some inactivation,
slower activation/deactivation kinetics, and a reduction
in basal activation. Moreover, roughly equal nanogram
Figure 1. KCNQ1/KCNE3 channels have a large standing
current at negative membrane potentials. (A) Two-electrode
voltage clamp recordings from Xenopus oocytes injected with Q1
(left) or Q1/E3 (right). Traces were recorded in KD98 with a 13-s
interpulse interval. Dashed line indicates zero current. Inset,
“Activation Curve Protocol” of 2-s depolarizations used to elicit
currents shown. (B) Voltage–activation curves from Q1 and Q1/
E3 channels. Tail currents were measured 3 ms after repolarization,
ﬁt to a Boltzmann, and the data normalized such that the upper
asymptote was equal to 1. Squares, Q1; circles, Q1/E3. Data were
averaged from six oocytes each   SEM. Scale bars represent 1  A
and 0.5 s.
Figure 2. KCNE3 truncation mutants. Solid lines depict which
amino acid residues remain in E3 truncation mutants. Numbers
across the top denote amino acid residue number. TM, transmem-
brane domain; N, putative N-linked glycosylation site.763 Gage and Kobertz
amounts of Q1 and COOH-terminal mutant RNA were
required to afford E3-like currents shown in Fig. 4 A;
typical injection ratios (1/0.1 Q1/KCNE) afforded cur-
rents with more Q1 character (vide infra). The electro-
physiological properties of COOH-terminal truncation
mutants in Table I are compared with WT E3 and the
NH2-terminal truncations, which were also injected at
this near equal RNA ratio for comparison.
Since the E3 transmembrane domain is able to mod-
ulate Q1 channels without the presence of a COOH-
terminal domain, we next asked whether a dysfunc-
tional mutation within the conserved COOH terminus
would affect Q1–E3 function. E1 peptides containing
the long QT–causing mutation D76N have been previ-
ously shown to assemble with Q1 channels and trafﬁc to
the plasma membrane, but are essentially nonconduct-
ing complexes (Fig. 5 A, left) (Wang and Goldstein,
1995). Incorporation of the corresponding mutation
into E3 (D90N) and coexpression with Q1 results in
currents nearly indistinguishable from wild type (Fig. 5
A, right). This functional rescue can be solely attrib-
uted to the E3 transmembrane domain since an E1/E3
chimera possessing the E3 transmembrane sequence
can also functionally rescue the D76N mutation, albeit
with slower activation and deactivation kinetics (Fig. 5
B). Although these mutants produce functional Q1–
E3 complexes, they required injecting more mutant E3
RNA than Q1 to produce currents with primarily E3
Figure 3. KCNE3 NH2-terminal truncation mutants produce standing currents at negative potentials when coexpressed with Q1. (A)
TEVC recordings from Xenopus oocytes injected with Q1 and either  5-40 (left),  10-51 (center), or  41-55 (right). Traces were recorded
in KD98 with a 13-s interpulse interval. Dashed line indicates zero current. Inset, “Activation Curve Protocol” of 2-s depolarizations used to
elicit currents shown. (B) Voltage–activation curves from E3 NH2-terminal truncation mutants. Activation curve data were ﬁt to a
Boltzmann, and the data renormalized as described in materials and methods. Squares,  5-40; circles,  10-51; triangles,  41-55. Dotted
lines indicate the voltage-independent activation of Q1 and Q1–E3 from the lower asymptotes of Q1 the corresponding Boltzmann ﬁts.
Data were averaged from four to six oocytes   SEM. Scale bars represent 1  A and 0.5 s.
Figure 4. KCNE3 COOH-terminal and combined NH2- and COOH-terminal truncation mutants also exhibit standing currents at
negative potentials when coexpressed with Q1. (A) TEVC recordings from Xenopus oocytes injected with Q1 and either  84 (left) or
 10-51/ 84 (right). Traces were recorded in KD98 with a 13-s interpulse interval. Dashed line indicates zero current. Scale bars represent
1  A and 0.5 s. Inset, “Activation Curve Protocol” of 2-s depolarizations used to elicit currents shown. (B) Voltage–activation curves from
KCNE3 COOH-terminal and double truncation mutants. Data were ﬁt to a Boltzmann, and normalized as described in materials and
methods. Squares,  84; circles,  10-51/ 84. Dotted lines indicate the voltage-independent activation of Q1 or Q1–E3 (E3). Data were
averaged from four oocytes each   SEM. (C) External K  concentration was varied and the reversal potential was measured. log[K ]ext is
plotted against observed reversal potential. WT and E3 truncation mutants coexpressed with Q1 produced linear ﬁts within error of 53 mV
per decade. Data was averaged from four to six oocytes   SEM.764 KCNE3 Truncation Mutants
character; injection of lower amounts of E3 resulted in
currents with more Q1 character, as was previously ob-
served with the E3 D90N mutation (Fig. 6 A) (Abbott
and Goldstein, 2002). These results demonstrate that
the E3 transmembrane domain is capable of function-
ally overriding the modulatory effects of the KCNE
COOH terminus.
To afford the characteristic Q1–E3 currents with the
D90N and COOH-terminal truncation mutants, an un-
usually high injection ratio of Q1:E3 RNA was required,
suggesting that the COOH terminus might be impor-
tant for cellular assembly and trafﬁcking of the Q1–E3
complex. Supporting this notion was the presence of in-
activation in the tail currents with the  84 and D90N
mutants at the lower injection ratios (Fig. 6 A). This in-
activation was not present in either WT Q1–E3 com-
plexes or in complexes where the majority of the E3
NH2 terminus is removed ( 10-51). Therefore, its pres-
ence with the  84 and D90N mutants indicated that a
mixed population of Q1 channels (unpartnered and E3
partnered) was functioning at the cell surface. To con-
ﬁrm that unpartnered Q1 channels were present and
functioning at the plasma membrane, we used chro-
manol 293B, which inhibits Q1–E3 complexes at a 10-
fold lower concentration than homomeric Q1 channels
(Schroeder et al., 2000). In the presence of 10  M chro-
manol 293B, WT and  10-51 mutant Q1–E3 complexes
were consistently inhibited at  85%, independent of
the ratio of RNA injected (Fig. 6 B). Conversely, as less
D90N or  84 RNA was injected, chromanol 293B inhi-
bition decreased, approaching the amount of inhibi-
tion observed with unpartnered Q1 channels at 10  M
chromanol 293B (Fig. 6 B, dotted line). Vehicle (0.1%
DMSO) alone had no effect on WT or mutant Q1–E3
complexes (unpublished data). At the highest RNA in-
jection ratio, there was consistently less total current re-
maining for the  84 and D90N mutant than with either
WT or the NH2-terminal truncation mutant ( 10-51).
Attempts to inject even more E3 mutant DNA to de-
termine whether unpartnered Q1 channels remained
at the cell surface with the 1/2.5 Q1/E3 ratio were
thwarted by extensive oocyte death. Nonetheless, lower-
ing the Q1:E3 RNA injection ratio with the COOH-ter-
TABLE I
Electrophysiological Properties of KCNE3 Truncation Mutants
 deactivation (ms)
Construct V1/2 (mV) z Basal Activation, A2 fast slow
Q1  23.8   0.6 1.39   0.03 0.03   0.01 221   10
E3 23.5   2.5 0.75   0.03 0.31   0.02 14.9   0.3 124   5
 5-40 25.3   5.1 0.81   0.07 0.35   0.03 19.1   1.2 130   5
 10-51 24.6   5.5 1.00   0.05 0.30   0.02 14.4   0.6 102   4
 41-55 86.4   7.4 0.51   0.01 0.12   0.01 10.9   0.2 115   3
 84 10.1   1.3 0.67   0.02 0.07   0.01 ND ND
 10-51/ 84  10.0   0.7 1.31   0.05 0.14   0.02 ND ND
D90N 27.8   4.1 0.59   0.02 0.28   0.02 13.7   0.4 156   28
E1/E3 TM D76N 4.5   4.3 0.82   0.03 0.08   0.01 ND ND
Data from individual activation curves and deactivation time constants in KD98, obtained from four to six oocytes. Activation curves were fit to a Boltzmann
function as described in materials and methods. Values are mean   SEM. Basal activation (A2) for all activation curves was determined by normalizing
the data after the Boltzmann fit such that the maximal current fitting parameter (A1) was equal to 1. V1/2 is the voltage of half-maximal activation and z is
the slope factor. Time constants of deactivation were fit to a single or double exponential as described in materials and methods. ND, not determined.
Figure 5. A long QT mutation in the COOH terminus of
KCNE1 is masked by the KCNE3 transmembrane domain. Inset,
“Activation Curve Protocol” of 2-s depolarizations used to elicit
currents shown. Scale bar represents 1  A and 0.5 s for all record-
ings. (A) TEVC recording from Xenopus oocytes injected with Q1
and either E1 D76N (left) or E3 D90N (right). (B) Representative
TEVC recordings from oocytes coinjected with Q1 and a chimeric
partner protein, E1 D76N with the E3 transmembrane (TM) se-
quence. All oocytes were injected with equal amounts and ratios of
Q1 and E1 or E3 RNA, and were recorded in KD98 using a 13-s
interpulse interval. Dashed lines indicate zero current.765 Gage and Kobertz
minal and D90N mutants decreased chromanol 293B
inhibition and mirrored the increase in inactivation,
suggesting that unpartnered Q1 channels were func-
tioning at the plasma membrane. These results impli-
cate the COOH terminus in Q1–E3 complex assembly.
We next determined whether the COOH-terminal
and D90N mutant protein was failing to form prop-
erly assembled complexes with Q1 and trafﬁc to the
plasma membrane, or whether the mutant proteins were
merely being degraded. To distinguish injected E3 pro-
tein from endogenous KCNE peptides recently identi-
ﬁed in Xenopus oocytes (Anantharam et al., 2003), we
used an HA-tagged version of E3 that has been previ-
ously used for biochemical experiments (Abbott et al.,
2001; McCrossan et al., 2003; Lewis et al., 2004). Incor-
poration of the NH2-terminal HA tag caused a unique
form of K -enhanced, cumulative inactivation in all
Q1–E3 complexes, including wild type (Fig. 7, A and
B). Initial recordings in low external K  (ND96) re-
quired holding at  80 mV for several minutes using
test depolarizations to monitor recovery from inactiva-
tion. Perfusion of 98 mM K  slowly inactivated the HA-
tagged Q1–E3 complex, which could not be reversed
with hyperpolarizing pulses (Fig. 7 B). Since the E3
HA-tagged Q1 complex does not recover from inactiva-
tion with voltage in high external K , no recovery
“hooks” in the tails were observed  upon  repolariza-
tion. Subsequent perfusion with ND96 could partially
relieve cumulative inactivation, but the currents never
returned to their original values. To ameliorate K -
enhanced cumulative inactivation of the HA-tagged
Q1–E3 complexes, we replaced the external K  with 10
mM Rb  (Fig. 7 C). At this concentration of Rb , we
could readily detect the “hook tails” associated with ho-
motetrameric Q1 inactivation since inward currents are
about threefold larger with external Rb  in comparison
to K  (Seebohm et al., 2003). Using these conditions,
Q1 complex assembly with the COOH-terminal trunca-
tion mutant ( 84) remained dependent on the ratio of
RNA injected and homotetrameric Q1 channels could
be detected at both injection ratios. Remarkably, addi-
tion of the epitope tag to the D90N mutant essentially
rescued the assembly defect of this mutant (Fig. 7 C).
Since Q1 complex assembly with the HA-tagged
 84 mutant remained dependent on the amount of
RNA injected in functional experiments, we next deter-
Figure 6. KCNE3 COOH-terminal mutants demonstrate a functional dependence on cRNA injection ratios. (A) Representative
two-electrode voltage clamp recordings taken from oocytes injected with varying amounts of E3, between 2.5x and 0.05x of Q1. Currents
were recorded in KD98, using a 13-s interpulse interval. The Q1:E3 ratio is labeled across the top. Top row, E3 (square); second row,
 10-51 (circle); third row,  84 (diamond); bottom row, D90N (triangle). Dashed lines indicate zero current. Scale bars represent 1  A
and 0.5 s. Inset, “Activation Curve Protocol” of 2-s depolarizations used to elicit currents shown. (B) Percent current remaining after
inhibition with 10  M chromanol 293B. Oocytes were held at  80 mV and depolarized for 2 s to   40 mV with a 28-s interpulse interval.
Current levels were allowed to stabilize for  5 min before 10  M chromanol 293B was perfused in. Chromanol inhibition typically
reached equilibrium within 5 min of wash in. Dashed line indicates the percentage of current remaining in oocytes expressing Q1 alone.
Data was averaged from 3–11 oocytes   SEM.766 KCNE3 Truncation Mutants
mined whether the E3 COOH-terminal mutants were
proteolytically stable. HA-tagged E3 proteins were iso-
lated from crude oocyte membranes after 3–5 d of
coexpression with Q1. Three oocytes worth of mem-
branes from each sample at the 1/0.4 Q1/E3 ratio were
analyzed by SDS-PAGE and transferred to nitrocellu-
lose for E3 detection. Immunoblots in Fig. 8 A showed
a similar complex pattern of bands for both WT E3 and
D90N, which is consistent with several N-linked gly-
coforms. The  84 COOH-terminal truncation mutant
protein also afforded an abundant signal on the immu-
noblot; however, only a single, intense band was ob-
served at 20 kD. The  84 protein was also detected at
the lower 1/0.05 Q1/E3 ratio (Fig. 8 B).
The markedly different pattern of protein bands for
WT and  84 suggested that the COOH-terminal trun-
cation mutant was largely residing in the ER, which
could be directly tested using E3 s N-linked glycosyla-
tion. N-glycosylated membrane proteins in the ER pos-
sess immature glycans ( 3 kD/glycan), whereas the
N-linked glycans on membrane proteins that have traf-
ﬁcked through the Golgi mature and often increase in
size due to the various trimming and additions of glyco-
sides. To identify the maturity of the N-linked glycans
on WT and  84, two glycosidases were used: endogly-
cosidase H (Endo H), which cleaves only the immature
glycoform, and PNGase F, which removes all forms
of N-linked glycosylation. SDS-solubilized membranes
containing WT and  84 protein were enzymatically de-
gylcosylated and separated on Tris-Tricine gels to re-
solve the  10–20-kD unglycosylated proteins (Fig. 8 B).
Endo H treatment of WT E3 removes only a single
band at 23 kD. Although the deglycosylated product
cannot be observed at this exposure, extended expo-
sures revealed a faint band at 17 kD, suggesting that the
majority of the protein has mature N-linked glycosyla-
tion (unpublished data). PNGase F treatment of WT
Figure 7. Functional characterization of KCNQ1/KCNE3–HA
complexes. (A) Q1 complexes formed with HA-tagged E3 exhibit
potassium-dependent inactivation. TEVC recordings of oocytes
expressing Q1 and E3-HA were bathed in ND96 (left) and KD98
(right). Both recordings are shown at the same scale, and use a
13-s interpulse interval. Insets, “Activation Curve Protocol” of 2-s
depolarizations used to elicit currents shown. (B) Current versus
time plotted for potassium concentration changes for the Q1–
E3–HA complex shown in A. Oocytes were held at  80 mV, and
depolarized for 2 s to   40 mV, with a 28-s interpulse interval.
Squares denote the current measured at  40 mV, triangles at
 80 mV 100 ms before the respective capacitive transients. (C)
HA-tagged E3 shows altered dose dependence for the COOH-
terminal truncation mutant. TEVC measurements of oocytes
injected with 0.4x (left) or 0.05x (right) E3–HA relative to Q1.
Currents were recorded with 10 mM Rb  (RD10), and oocytes
were held at  40 mV, with an 11.5-s interpulse interval. Top,
E3–HA; middle,  84–HA; bottom, D90N–HA. Scale bars represent
1  A and 0.5 s.767 Gage and Kobertz
E3 demonstrated that the remaining, slower mobility
bands were due to mature N-linked glycosylation, as all
bands collapsed to a single species at  17 kD. In con-
trast, both glycosidases equally acted on the single band
in the  84 sample, identifying the N-linked glycan as
the immature form found in the ER. Given the small
size of the  84 mutant, the slight difference in protein
mobility for the differently deglcosylated samples is
presumably due to the remaining monosaccharides left
behind after Endo H treatment. PNGase F, in contrast,
removes all of the carbohydrate from each N-glycosyla-
tion site, resulting in a protein with a smaller molecular
weight. These results demonstrate that the COOH ter-
minus is important for assembling Q1–E3 complexes
that efﬁciently exit the ER.
As shown in Fig. 8 B, the PNGase F–treated  84
samples were routinely stronger in intensity than when
treated with Endo H. This difference suggested that
some mature glycoforms of  84 may have been present,
but were not detectable in the immunoblot due to the
heterogeneity of mature glycosylation that often causes
an underrepresentation of the protein signal. To en-
sure that a small portion of the HA-tagged  84 was
reaching the plasma membrane, we used whole oocyte
cell surface labeling in combination with chemilumi-
nescence to detect the extracellularly HA-tagged E3
proteins on the cell surface (Zerangue et al., 1999).
Whole oocytes coexpressing Q1 with HA-tagged E3
proteins were labeled with anti-HA antibody followed
by labeling with a secondary HRP-conjugated antibody.
The amount of secondary antibody on the cell surface
of each oocyte was quantitated using a luminometer.
Strong cell surface signals were observed for WT and
D90N (Fig. 8 C). Cell surface expression of  84 was eas-
ily detected over Q1-injected background controls, but
was noticeably less than WT and D90N. These cell sur-
face expression data are in agreement with the bio-
chemistry and electrophysiological experiments, which
in total demonstrate that the E3 COOH terminus
aides in cellular assembly and trafﬁcking of the Q1–E3
complex.
DISCUSSION
In this study, we have used the dramatic changes in Q1
channel function to assess Q1–E3 complex assembly,
and by deﬁnition, the region of E3 responsible for
basal activation of the complex. Through a series of
truncation mutants, exempliﬁed by a 41-residue double
truncation mutant that is active, yet lacks the majority
of its NH2 and COOH termini, we have shown that the
transmembrane domain of E3 is sufﬁcient for assembly
with and modulation of Q1 channels. A comparative
analysis of gating revealed that truncation of the major-
ity of the NH2 terminus does not appreciably alter Q1–
E3 basal activation as long as one putative N-linked gly-
Figure 8. WT and COOH-terminal mutant HA-tagged KCNE3 peptides are glycosylated and not proteolytically degraded in oocytes.
Crude membranes for the immunoblots were prepared 3–5 d after coinjection with Q1 and the indicated E3 construct. (A) Immunoblot
of HA-tagged E3 peptides from SDS-solubilized membranes isolated from oocytes injected at a Q1/E3 ratio of 1/0.4. Membranes from
three oocytes were loaded in each lane and resolved with a 15% Tris-glycine SDS gel. Molecular weight standards are labeled on the left for
both blots. (B) Immunoblots of enzymatically deglycosylated E3 and  84 HA-tagged proteins were separated on 16.5% Tris-tricine SDS
gels. E3 (four oocytes/lane) and  84 (six oocytes/lane) were digested with endoglycosylase Hf (Endo H) or PNGase F. Lane marked ( )
represents untreated samples. Loaded in the lane marked 1/0.05 are solubilized membranes from 17 oocytes expressing Q1/ 84 injected
at the lowest Q1/E3 ratio examined. Membranes from uninjected oocytes are denoted and were loaded at the left (4 oocytes) and right
(17 oocytes). Mature and immature glycosylation is denoted, as determined by enzymatic deglycosylation. (C) Cell surface expression of
HA-tagged E3 proteins was quantitated by single oocyte chemiluminescence. Oocytes were injected with a 1/0.4 Q1/E3 ratio, allowed to
incubate for 5 d, and the cell surface–tagged proteins were labeled with an anti-HA antibody followed by a secondary HRP-conjugated
antibody. Single oocyte luminescence was quantitated in a luminometer and is reported in relative light units (RLU). Q1 sample is from
control oocytes injected with only Q1 RNA. Error bars are standard error measurement from 15–19 oocytes.768 KCNE3 Truncation Mutants
cosylation site is retained. The importance of N-linked
glycosylation in Q1–KCNE complex formation and func-
tion has been previously observed with E1 (Takumi et
al., 1991; Freeman et al., 2000). A requirement of using
tail current analysis to compare the basal activation of
these mutants is that the channel complexes must be
sufﬁciently activated past their midpoint of activation
to ﬁt the data accurately to a Boltzmann. Any uncer-
tainty in the upper asymptote of the ﬁt will greatly af-
fect the value determined for the basal activation. The
 41-55 highlights this caveat since its basal activation is
apparently reduced; however, this mutant clearly forms
complexes with Q1 channels that are open at hyperpo-
larizing potentials, which cause a substantial lowering
of the oocyte resting potential similarly to WT E3.
Mutants that allow unpartnered Q1 channels to es-
cape the ER and function at the plasma membrane
would also affect the measurement of basal activation.
The lower basal activation of the COOH-terminal trun-
cation mutants may be due in part to unpartnered Q1
channels affecting the activation curve analysis, which
was supported by the following three observations
in electrophysiological experiments where the Q1/E3
RNA injection ratio was systematically varied. (1) The
COOH-terminal truncation and D90N point mutants
required injecting more E3 RNA than Q1 to afford the
characteristic Q1–E3 currents. Moreover, as relatively
less E3 RNA was injected, the resulting currents resem-
bled unpartnered Q1 channels. In contrast, Q1 com-
plexes with WT and the NH2-terminal E3 truncation
mutant ( 10-51) always afforded Q1–E3-like currents
over a similar 50-fold range of E3 RNA. (2) The pres-
ence of homotetrameric Q1 inactivation, as observed
by the hook in the tail currents upon repolarization,
was detected only with the COOH-terminal mutants
and increased as less E3 RNA was injected. (3) The
chromanol 293B sensitivity, an indirect measurement
of Q1–E3 complex assembly, was reduced for the COOH-
terminal mutants and was also dependent on the Q1/
E3 RNA injection ratio. These observations strongly im-
ply that a heterogeneous population of Q1 channels is
at the cell surface when coexpressed with E3 COOH-
terminal mutants; however, these observations do not
rule out the possibility that there are more than two
populations of Q1 channels functioning at the plasma
membrane. The diminished assembly capacity of the
COOH-terminal mutants, which allows unpartnered
Q1 channels to trafﬁc to the plasma membrane, also
explains an apparent inconsistency with a previous in-
vestigation of the D90N mutant. Injection at more typi-
cal Q1/KCNE RNA ratios (1/0.1) results in currents
with primarily Q1 character, as was previously observed
with this mutant (Abbott and Goldstein, 2002). It is not
until a large excess of D90N RNA is injected that Q1–
E3 currents are consistently observed.
Biochemical examination of the E3 COOH-terminal
mutant proteins necessitated the use of an epitope-
tagged E3 construct since oocytes contain endogenous
KCNE peptides (Anantharam et al., 2003). Although
this particular HA-tagged E3 construct has been previ-
ously used in biochemical experiments (Abbott et al.,
2001; McCrossan et al., 2003; Lewis et al., 2004), in our
hands, we observed a unique form of inactivation when
it assembled with Q1 that was enhanced by high exter-
nal K  and not reversible with hyperpolarizing pulses
under these high K  conditions. Surprisingly, incorpo-
ration of the HA tag into the D90N mutant enabled
this assembly-defective mutant to readily assemble
with Q1 channels. We observed efﬁcient Q1–D90N–HA
complex assembly in all three assays tested: RNA titra-
tion, maturation of glycosylation, and cell surface ex-
pression. The HA tag had little effect on the  84 mu-
tant, as it remained assembly impaired and dependent
on RNA injection ratios. While the addition of the HA
tag does add two extra negative charges per KCNE sub-
unit, and it is has been shown that these charges are
in the vicinity of the outer vestibule of the Q1 chan-
nel (Chen et al., 2003), any proposed mechanisms
for either of these two observed phenomena would be
conjecture.
The ﬁnding that the majority of the  84 mutant pro-
tein possesses the immature form of N-linked glycosyla-
tion indicates that the COOH terminus assists in the
proper assembly of Q1–E3 complexes that can efﬁ-
ciently exit the ER. In addition, the fact that only the
immature core oligosaccharide is observed for the  84
mutant, and not the unglycosylated peptide, demon-
strates that COOH-terminal truncation mutant is rec-
ognized by oligosaccharyltransferase and is treated as a
bona ﬁde substrate. The presence of the immature gly-
can on  84 is also consistent with Q1–KCNE complex
formation occurring in the ER, which is in agreement
with several recent studies that suggest Q1–KCNE com-
plex formation occurs in the ER (Bianchi et al., 2003;
Krumerman et al., 2004). Although no mature form of
 84 was directly observed in the Western blots, cell sur-
face labeling of individual oocytes conﬁrmed that at
least a small portion of the  84 mutant protein was in-
deed at the cell surface. The presence of immature  84
protein in both the low and high RNA injection ratios
indicates that the protein resides in the ER, but is un-
able to prevent unpartnered Q1 channels from escap-
ing the ER. These results, however, do not directly
address whether the majority of the  84 protein is
retained in the ER, and not assembled with Q1, or
whether the assembled Q1–E3 complexes lacking an
E3 COOH terminus are not passing the protein quality
control (QC) mechanisms in the ER. The most likely
QC proteins involved in ER retention are calnexin/cal-
reticulin since the  84 mutant lacks a COOH terminus,769 Gage and Kobertz
eliminating the possibility of a cytoplasmic ER reten-
tion signal (Ellgaard and Helenius, 2003). The lack of
an ER retention signal also argues that  84 mutant is
retained in the ER and not reﬂuxing back from the cis-
Golgi since COPI proteins require these motifs for ret-
rograde trafﬁcking (Ellgaard and Helenius, 2003).
Our ﬁndings directly bear on the controversy regard-
ing the locations of the assembly and modulation
domains of E1 and E3. The current debate revolves
around assigning assembly and modulatory properties
to two distinct locations: the transmembrane domain
and a highly conserved region within the COOH termi-
nus. Deletion analysis of E1 initially demonstrated that
the transmembrane domain was sufﬁcient for assem-
bly with Q1 channels, but the COOH terminus was re-
quired for modulation (Tapper and George, 2000).
More recent E1/E3 chimeras suggest exactly the oppo-
site: the transmembrane sequence houses the modula-
tory domain while the COOH terminus anchors and
properly positions the KCNE peptide within the Q1
channel complex (Melman et al., 2001). In the context
of these previous reports, the results from our E3 trun-
cation and point mutants suggest a bipartite model for
assembly and modulation. In this model (Fig. 9), the
transmembrane domain and the conserved COOH-ter-
minal region both play a role in assembly. The trans-
membrane domain is the primary player in Q1–KCNE
complex assembly, but the COOH terminus also aids in
assembling competent complexes, as evidenced by the
“assembly-challenged” E3 COOH-terminal truncation
mutants, E3 D90N mutant and D76N E1/E3 chimera.
For modulation, the KCNE transmembrane sequence
is either active or passive in basal activation. In the case
of E3, the transmembrane domain is active and over-
rides the COOH terminus, affording a Q1 channel
complex with large basal activation. Conversely, the E1
transmembrane domain is passive and reveals COOH-
terminal modulation of Q1, producing slowly activating
and deactivating IKs currents. The bipartite model also
predicts that a dysfunctional COOH terminus would
have no effect on E3 modulation of Q1, but would be
detrimental to Q1–E1 complex function. Incorpora-
tion of such mutation into E3 (D90N) had no effect on
Q1–E3 complex function, whereas this same long QT
mutation in E1 renders the complex nonfunctional.
And with some ghoulish tinkering (placing the E3
transmembrane sequence into the E1 D76N mutant),
we demonstrated that the E3 transmembrane domain
alone was sufﬁcient to mitigate the disruptive effects of
this COOH-terminal mutation.
Is bipartite assembly and modulation exclusive to E1
and E3? Based on sequence homology, previous dele-
tion studies with E1 (Tapper and George, 2000) and
our E3 truncation mutants show that the KCNE trans-
membrane segment is a general, minimal Q1 assembly
domain. Although the KCNE COOH terminus is not as
conserved as the transmembrane domain throughout
the entire family, there is some evidence that the E1
COOH terminus may also be important for Q1–E1
complex assembly. Previous E1 deletion studies initially
suggested that the COOH terminus was solely involved
in modulation, since removing it did not prevent com-
plex formation with Q1 channels (Tapper and George,
2000). However, complex formation was not readily ap-
parent from the current traces (the raw data was nearly
indistinguishable from unpartnered Q1 currents) and
a cysteine residue had to be incorporated into the E1
transmembrane domain so that Q1–E1 complex for-
mation could be detected by cadmium inhibition. Al-
though cadmium inhibition was clearly detected in
these mutants, it was noticeably less than WT Q1–E1
complexes (Tapper and George, 2000), suggesting that
a population of unpartnered Q1 channels may have
also been present and functioning at the cell surface.
Further examination of the COOH terminus of E1, as
well as the remaining KCNE peptides, will reveal whether
this region facilitates Q1–KCNE complex formation in
the entire KCNE family.
Transmembrane modulation, and thus the bipartite
model, may be limited to KCNE modulation that in-
volves altering the basal activation of Q1 channels.
Figure 9. A bipartite model for modulation of KCNQ1 by
KCNE1 and KCNE3. Net diagrams of the transmembrane domains
of E1 and E3 are aligned; amino acid residues, denoted as circles,
are shaded based on conservation. Black circles, identical amino
acids; gray circles, similar amino acids; horizontally striped circles,
high-impact amino acids identiﬁed by chimeric studies; vertically
striped circles, D76 and D90; no ﬁll, nonsimilar amino acids; TM,
transmembrane domain.770 KCNE3 Truncation Mutants
Given the reported proximity of the KCNE transmem-
brane segment to the S6 helix (Wang et al., 1996; Tai
and Goldstein, 1998; Tapper and George, 2001), we
view E3 transmembrane modulation of Q1 similarly to
the constitutively activated S6 mutants in the Shaker K 
channel described by Swartz and coworkers (Hackos et
al., 2002). Whether the basal activation of the Q1–E3
complex is due to a subconducting leaky closed state, a
perturbed closed to open equilibrium, or a supplanta-
tion of an obliterated cytoplasmic gate by an alternative
voltage-activated gating mechanism is yet to be deter-
mined. This perspective of channel gating provides a
rationalization of the E1/E3 chimera data where a sin-
gle point mutation (Melman et al., 2002a,b) can essen-
tially convert E1 into E3 by inducing basal activation by
one of the aforementioned gating mechanisms.
Our discovery of COOH-terminal E3 mutants that
are assembly compromised brings up an important is-
sue that has not been directly addressed in the KCNE
literature. Several elegant studies have shown signiﬁ-
cant electrophysiological changes when KCNE peptides
are coexpressed with many types of voltage-gated K 
channels; however, the percent of functioning K  chan-
nels assembled with KCNE peptides at the cell surface
was never directly determined. While we could show
that the COOH-terminal E3 mutants were assembly
challenged using RNA ratio titration experiments in
combination with chromanol 293B pharmacology, we
could not accurately determine the fraction of unpart-
nered Q1 channels at the cell surface. The develop-
ment of new methods that directly determine the ratio
of partnered and unpartnered K  channels function-
ing at the plasma membrane would be of great value in
structure/function studies of K  channel–KCNE com-
plexes and may help corroborate the physiological rele-
vance of many of these newly identiﬁed complexes.
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